Sabin and IPA Continue Advocacy Efforts Towards Measles and Rubella Elimination

03.14.13
From 19-22 February 2013, Sabin Executive Vice-President Dr. Ciro de Quadros and Program Officer Brian Shaw participated in the SEARO Regional Consultation on Measles Elimination and Rubella/CRS Control, held in Kathmandu, Nepal. As a member of the Measles Rubella Initiative (MRI), Sabin is committed to the elimination of measles, rubella & congenital rubella syndrome (CRS).
Read more

Rwanda first sub-Saharan African country to introduce measles-rubella vaccine

03.12.13
Rwanda’s measles-rubella vaccination campaign, which is being launched today, is the beginning of an effort to vaccinate more than 700 million children under 15 years of age against two disabling and deadly diseases.
Read more

Vaccine Advocacy & Education

The Vaccine Advocacy and Education program at Sabin is dedicated to reducing the burden of preventable diseases by bringing together key stakeholders and leaders in government, private sector and civil society in order to foster cooperation, share information and best practices, and develop improved vaccine policy and access.

GAVI: Delivering on the Promise

06.13.12
One year ago at the GAVI Alliance pledge conference, partners exceeded expectations by pledging $4.3 billion dollars.
Read more

Smallpox Eradication Continues to Inspire Innovations in Global Health

04.24.12

Dr. de Quadros and Hotez featured in Vaccine special supplement!

Read more

Progress Toward Rubella Elimination and CRS Prevention in Europe

View event +

XIX Meeting of the Technical Advisory Group (TAG)

Sabin's picture Submitted by Sabin on

July 13, 2011

The XIX Meeting of the Technical Advisory Group (TAG) was held from July 6-8, 2011 in Buenos Aires, Argentina. Experts from the Pan American Health Organization / World Health Organization (PAHO/WHO) gathered to acknowledge great strides made in vaccine development and distribution, along with discussing next steps for future success.

Subscribe to RSS - rubella